Archana Bindra, MD
Endocrinology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bindra’s office at (408) 866-4070 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A75781 · Current
Licensed to practise in California · since 2001 · expires 2027-06-30 · University of Bombay, Seth G. S. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$150,021
Medicare paid this office $150,021 for 357 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 276 | $67,246 | $114 |
| Injection, denosumab, 1 mg | 24 | $41,049 | None |
| New patient visit (45+ min) | 61 | $8,852 | $145 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 107 | $7,466 | $29 |
| New patient visit (30+ min) | 34 | $3,439 | $101 |
See all 9 services
| Return visit (30+ min) | 276 | $67,246 | $114 |
| Injection, denosumab, 1 mg | 24 | $41,049 | None |
| New patient visit (45+ min) | 61 | $8,852 | $145 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 107 | $7,466 | $29 |
| New patient visit (30+ min) | 34 | $3,439 | $101 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 53 | $2,560 | $23 |
| Hemoglobin a1c level | 140 | $2,409 | $9 |
| Short return visit (20+ min) | 23 | $2,161 | $90 |
| Injection of drug or substance under skin or into muscle | 21 | $440 | $15 |
Who their Medicare patients are
357 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 11% · Women 63% · Also on Medicaid 15% · Health risk score 1.42. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 67% · Chronic kidney disease 37% · Coronary heart disease 26% · Depression 18% · Heart failure 17% · Atrial fibrillation 15% · Cancer 13% · COPD 11% · Stroke 9% · Dementia 5%.
The office billed $579,975, Medicare allowed $198,417 and paid $150,021; for 4,616 services of 17 kinds; $54,845 of it was for drugs given in the office and $95,176 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 357 | 4,616 | 74 | 1.42 | $579,975 | $150,021 |
| 2023 | 247 | 2,917 | 74 | 1.35 | $400,223 | $100,273 |
| 2022 | 224 | 1,825 | 73 | 1.51 | $302,213 | $75,400 |
| 2021 | 191 | 773 | 73 | 1.49 | $242,899 | $69,224 |
| 2020 | 180 | 739 | 73 | 1.74 | $186,556 | $49,507 |
| 2019 | 312 | 1,559 | 72 | 1.84 | $220,295 | $90,304 |
| 2018 | 287 | 2,145 | 71 | 1.90 | $304,113 | $133,334 |
| 2017 | 305 | 2,276 | 72 | 1.97 | $243,987 | $113,443 |
| 2016 | 292 | 1,779 | 72 | 1.88 | $183,822 | $88,542 |
| 2015 | 285 | 1,735 | 72 | 2.00 | $158,744 | $78,056 |
| 2014 | 256 | 1,956 | 73 | 1.79 | $171,337 | $83,335 |
| 2013 | 243 | 2,109 | 73 | 1.88 | $184,500 | $89,621 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 214 | $60,607 | $114 |
| New patient visit (45+ min) | 74 | $10,802 | $146 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 86 | $6,582 | $30 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 30 | $1,548 | $22 |
| Hemoglobin a1c level | 17 | $162 | $10 |
2022: 5 services
| Return visit (30+ min) | 180 | $51,941 | $114 |
| New patient visit (45+ min) | 87 | $13,280 | $153 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 73 | $5,073 | $30 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $2,356 | $112 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 32 | $1,583 | $23 |
2021: 7 services
| Return visit (30+ min) | 137 | $42,263 | $115 |
| New patient visit (45+ min) | 66 | $9,854 | $149 |
| Telephone medical discussion with physician, 21-30 minutes | 43 | $7,036 | $117 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 53 | $3,568 | $30 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $2,888 | $85 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 40 | $1,749 | $22 |
| Administration of influenza virus vaccine | 12 | $261 | $22 |
2020: 10 services
| Return visit (30+ min) | 110 | $21,312 | $94 |
| New patient visit (45+ min) | 61 | $8,318 | $136 |
| Telephone medical discussion with physician, 11-20 minutes | 51 | $5,591 | $71 |
| Short return visit (20+ min) | 47 | $4,099 | $52 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,484 | $104 |
| New patient visit (30+ min) | 27 | $2,008 | $74 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 51 | $1,722 | $19 |
| Telephone medical discussion provided by nonphysician professional, 21-30 minutes | 19 | $968 | $37 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 17 | $765 | $32 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $746 | $39 |
2019: 16 services
| Return visit (30+ min) | 253 | $62,723 | $89 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 47 | $7,637 | $153 |
| New patient visit (45+ min) | 35 | $4,464 | $128 |
| Short return visit (20+ min) | 51 | $3,871 | $65 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 55 | $2,358 | $31 |
| Hemoglobin a1c level | 85 | $1,226 | $11 |
| Vitamin d-3 level | 26 | $902 | $32 |
| Blood test, basic group of blood chemicals (calcium, total) | 67 | $764 | $9 |
| Blood test, thyroid stimulating hormone (tsh) | 28 | $659 | $18 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 55 | $533 | $8 |
| Insertion of needle into vein for collection of blood sample | 99 | $420 | $3 |
| Blood test, lipids (cholesterol and triglycerides) | 25 | $379 | $15 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $342 | $23 |
| Thyroxine (thyroid chemical), free | 17 | $206 | $10 |
| Blood test, comprehensive group of blood chemicals | 14 | $161 | $12 |
| Urine microalbumin (protein) level | 22 | $138 | $6 |
2018: 16 services
| Return visit (30+ min) | 239 | $75,544 | $90 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 131 | $23,212 | $154 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 144 | $13,191 | $49 |
| New patient visit (45+ min) | 47 | $5,171 | $110 |
| Short return visit (20+ min) | 62 | $4,994 | $53 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 112 | $3,956 | $31 |
| Hemoglobin a1c level | 76 | $1,175 | $12 |
| Blood test, thyroid stimulating hormone (tsh) | 38 | $895 | $20 |
| Vitamin d-3 level | 20 | $752 | $36 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 66 | $714 | $9 |
| Blood test, basic group of blood chemicals (calcium, total) | 50 | $644 | $10 |
| Blood test, lipids (cholesterol and triglycerides) | 28 | $486 | $16 |
| Insertion of needle into vein for collection of blood sample | 111 | $485 | $3 |
| Blood test, comprehensive group of blood chemicals | 27 | $371 | $13 |
| Thyroxine (thyroid chemical), free | 18 | $251 | $11 |
| Urine microalbumin (protein) level | 26 | $189 | $7 |
2017: 15 services
| Return visit (30+ min) | 257 | $63,013 | $83 |
| Short return visit (20+ min) | 143 | $14,904 | $59 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 86 | $13,658 | $150 |
| New patient visit (45+ min) | 38 | $4,590 | $121 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 75 | $2,900 | $36 |
| Hemoglobin a1c level | 117 | $2,453 | $13 |
| Blood test, thyroid stimulating hormone (tsh) | 76 | $2,101 | $23 |
| Vitamin d-3 level | 42 | $1,711 | $40 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 94 | $1,327 | $10 |
| Blood test, basic group of blood chemicals (calcium, total) | 90 | $1,302 | $11 |
| Thyroxine (thyroid chemical), free | 51 | $812 | $12 |
| Insertion of needle into vein for collection of blood sample | 152 | $717 | $3 |
| Blood test, comprehensive group of blood chemicals | 39 | $639 | $13 |
| Blood test, lipids (cholesterol and triglycerides) | 34 | $482 | $13 |
| Urine microalbumin (protein) level | 47 | $389 | $8 |
2016: 15 services
| Return visit (30+ min) | 238 | $57,050 | $86 |
| Short return visit (20+ min) | 123 | $11,406 | $54 |
| New patient visit (45+ min) | 34 | $4,352 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,838 | $167 |
| Blood test, thyroid stimulating hormone (tsh) | 72 | $2,221 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,164 | $58 |
| Hemoglobin a1c level | 96 | $1,827 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 73 | $996 | $10 |
| Blood test, comprehensive group of blood chemicals | 48 | $772 | $14 |
| Blood test, basic group of blood chemicals (calcium, total) | 54 | $731 | $11 |
| Vitamin d-3 level | 17 | $711 | $40 |
| Insertion of needle into vein for collection of blood sample | 120 | $591 | $3 |
| Thyroxine (thyroid chemical), free | 34 | $589 | $12 |
| Blood test, lipids (cholesterol and triglycerides) | 21 | $323 | $13 |
| Urine microalbumin (protein) level | 24 | $216 | $8 |
2015: 18 services
| Return visit (30+ min) | 192 | $31,325 | $88 |
| Short return visit (20+ min) | 189 | $27,921 | $61 |
| New patient visit (45+ min) | 38 | $5,155 | $136 |
| Blood test, thyroid stimulating hormone (tsh) | 75 | $2,398 | $22 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,294 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,886 | $61 |
| Blood test, comprehensive group of blood chemicals | 62 | $1,136 | $14 |
| Hemoglobin a1c level | 67 | $1,088 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 72 | $1,016 | $10 |
| Short return visit | 20 | $775 | $32 |
| Thyroxine (thyroid chemical), free | 36 | $685 | $12 |
| Insertion of needle into vein for collection of blood sample | 129 | $638 | $3 |
| Vitamin d-3 level | 13 | $513 | $39 |
| Urine microalbumin (protein) level | 35 | $285 | $8 |
| Blood test, basic group of blood chemicals (calcium, total) | 23 | $270 | $11 |
| Blood test, lipids (cholesterol and triglycerides) | 17 | $255 | $13 |
| Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) | 22 | $220 | $9 |
| Blood count, hemoglobin | 29 | $101 | $3 |
2014: 16 services
| Short return visit (20+ min) | 173 | $31,128 | $60 |
| Return visit (30+ min) | 177 | $26,205 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $5,632 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,805 | $114 |
| New patient visit (45+ min) | 23 | $3,060 | $133 |
| Hemoglobin a1c level | 119 | $2,488 | $13 |
| Blood test, thyroid stimulating hormone (tsh) | 69 | $2,090 | $22 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 83 | $1,071 | $10 |
| Vitamin d-3 level | 23 | $990 | $40 |
| Blood test, comprehensive group of blood chemicals | 60 | $961 | $14 |
| Blood test, basic group of blood chemicals (calcium, total) | 52 | $805 | $11 |
| Insertion of needle into vein for collection of blood sample | 143 | $726 | $3 |
| Short return visit | 14 | $672 | $37 |
| Thyroxine (thyroid chemical), free | 38 | $651 | $12 |
| Blood test, lipids (cholesterol and triglycerides) | 31 | $444 | $13 |
| Urine microalbumin (protein) level | 32 | $278 | $8 |
2013: 20 services
| Short return visit (20+ min) | 156 | $34,537 | $62 |
| Return visit (30+ min) | 172 | $19,258 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $10,843 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,985 | $166 |
| Blood test, thyroid stimulating hormone (tsh) | 75 | $2,318 | $23 |
| Hemoglobin a1c level | 113 | $2,283 | $13 |
| New patient visit (45+ min) | 13 | $1,835 | $141 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 11 | $1,784 | $162 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,581 | $113 |
| Vitamin d-3 level | 33 | $1,481 | $40 |
| Short return visit | 28 | $1,257 | $39 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 82 | $1,062 | $11 |
| Blood test, comprehensive group of blood chemicals | 55 | $831 | $14 |
| Insertion of needle into vein for collection of blood sample | 130 | $673 | $3 |
| Urine microalbumin (protein) level | 77 | $665 | $8 |
| Blood test, basic group of blood chemicals (calcium, total) | 46 | $618 | $11 |
| Thyroxine (thyroid chemical), free | 36 | $598 | $12 |
| Blood test, lipids (cholesterol and triglycerides) | 35 | $537 | $14 |
| Creatinine level to test for kidney function or muscle injury | 63 | $483 | $7 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 13 | $438 | $34 |
Medicaid work
$79,087 in 2019
Medicaid paid $79,087 for 1,057 billed services this clinician did in 2019, up to 103 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 790 | $60,744 |
| Short return visit (20+ min) | 144 | $8,287 |
| New patient visit (45+ min) | 68 | $5,739 |
| Collection and interpretation of physiologic data (eg, ECG, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the physician or other qualified health care professional, qualified by education, training, licensure/regulation (when applicable) requiring a minimum of 30 minutes of time, each 30 days | 55 | $4,317 |
| 2019 | 1,057 | 4 | 103 | $79,087 |
| 2018 | 1,539 | 6 | 94 | $106,642 |
See the largest Medicaid services in earlier years
2018
| Return visit (30+ min) | 1,033 | $77,320 |
| Short return visit (20+ min) | 267 | $15,310 |
| New patient visit (45+ min) | 104 | $10,133 |
| Collection and interpretation of physiologic data (eg, ECG, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the physician or other qualified health care professional, qualified by education, training, licensure/regulation (when applicable) requiring a minimum of 30 minutes of time, each 30 days | 108 | $3,748 |
| Hemoglobin A1C level | 14 | $131 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; physician or other qualified health care professional (office) provided equipment, sensor placement, hook-up, calibration of monitor, patient training, removal of sensor, and printout of recording | 13 | $0 |
Drugs they prescribed that Part D paid
$1,955,926
Pharmacies billed $1,955,926 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,222) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
1,702 generic and 2,110 brand-name prescriptions · $1,955,926 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 395 | $635,568 | $1,609 |
| Jardiance | 348 | $440,962 | $1,267 |
| Mounjaro | 145 | $201,419 | $1,389 |
| Trulicity | 61 | $101,065 | $1,657 |
| Tresiba Flextouch U-200 | 63 | $72,220 | $1,146 |
See all 49 drugs
| Ozempic | 395 | $635,568 | $1,609 |
| Jardiance | 348 | $440,962 | $1,267 |
| Mounjaro | 145 | $201,419 | $1,389 |
| Trulicity | 61 | $101,065 | $1,657 |
| Tresiba Flextouch U-200 | 63 | $72,220 | $1,146 |
| Humulin R U-500 Kwikpen | 36 | $53,514 | $1,486 |
| Farxiga | 41 | $52,345 | $1,277 |
| Tresiba Flextouch U-100 | 92 | $46,059 | $501 |
| Humalog Kwikpen U-100 | 183 | $33,427 | $183 |
| Lantus Solostar | 229 | $27,439 | $120 |
| Prolia | 14 | $24,029 | $1,716 |
| Nano 2nd Gen Pen Needle | 254 | $23,324 | $92 |
| Repatha Sureclick | 33 | $17,697 | $536 |
| Fiasp Flextouch | 25 | $15,581 | $623 |
| Basaglar Kwikpen U-100 | 35 | $12,292 | $351 |
| Toujeo Solostar | 11 | $11,110 | $1,010 |
| Novolog Flexpen | 51 | $10,394 | $204 |
| Testosterone | 23 | $9,587 | $417 |
| Insulin Lispro Kwikpen U-100 | 33 | $6,521 | $198 |
| Repaglinide | 143 | $6,266 | $44 |
| Levothyroxine | 365 | $5,192 | $14 |
| Humalog | 25 | $5,171 | $207 |
| Synthroid | 60 | $5,166 | $86 |
| Ultra-Fine Mini Pen Needle | 42 | $4,196 | $100 |
| Ultra-Fine Short Pen Needle | 25 | $2,936 | $117 |
| Fenofibrate | 17 | $2,372 | $140 |
| Metformin Hcl Er | 132 | $2,241 | $17 |
| Atorvastatin | 122 | $2,126 | $17 |
| Metformin | 202 | $2,009 | $10 |
| Lantus | 18 | $1,910 | $106 |
| Ultra-Fine Nano Pen Needle | 13 | $1,517 | $117 |
| Rosuvastatin | 65 | $1,483 | $23 |
| Testosterone Cypionate | 31 | $1,425 | $46 |
| Insulin | 23 | $1,298 | $56 |
| Gabapentin | 56 | $1,001 | $18 |
| Losartan | 62 | $948 | $15 |
| Calcitriol | 18 | $864 | $48 |
| Alendronate | 76 | $805 | $11 |
| Amlodipine Besylate | 75 | $727 | $10 |
| Techlite Pen Needle | 11 | $675 | $61 |
| Glimepiride | 43 | $640 | $15 |
| Lisinopril | 42 | $437 | $10 |
| Simvastatin | 30 | $402 | $13 |
| Hydrocortisone | 20 | $248 | $12 |
| Metoprolol | 14 | $234 | $17 |
| Pravastatin | 13 | $228 | $18 |
| Glipizide | 20 | $180 | $9 |
| Methimazole | 27 | $151 | $6 |
| Hydrochlorothiazide | 25 | $107 | $4 |
Year by year
| 2024 | 4,222 | 585 | 0% (0) | 50% | $1,955,926 |
| 2023 | 3,518 | 446 | 0% (0) | 51% | $1,951,050 |
| 2022 | 3,136 | 362 | 0% (0) | 55% | $1,540,838 |
| 2021 | 2,836 | 309 | 0% (0) | 54% | $1,222,532 |
| 2020 | 2,126 | 335 | 0% (0) | 51% | $817,301 |
| 2019 | 3,129 | 300 | 0% (0) | 54% | $1,309,813 |
| 2018 | 3,471 | 283 | 0% (0) | 54% | $1,415,906 |
| 2017 | 3,342 | 267 | 0% (0) | 51% | $1,184,426 |
| 2016 | 2,872 | 256 | 0% (0) | 52% | $906,550 |
| 2015 | 2,385 | 242 | None | 50% | $663,990 |
| 2014 | 1,819 | 200 | 0% (0) | 48% | $443,962 |
| 2013 | 1,450 | 171 | 0% (0) | 43% | $213,732 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 49 drugs
| Ozempic | 267 | $466,353 | $1,747 |
| Jardiance | 365 | $387,587 | $1,062 |
| Trulicity | 129 | $248,897 | $1,929 |
| Lantus Solostar | 186 | $130,226 | $700 |
| Humalog Kwikpen U-100 | 132 | $99,494 | $754 |
| Novolog Flexpen | 68 | $67,740 | $996 |
| Tresiba Flextouch U-200 | 50 | $64,040 | $1,281 |
| Mounjaro | 26 | $58,004 | $2,231 |
| Farxiga | 65 | $56,770 | $873 |
| Tresiba Flextouch U-100 | 69 | $49,858 | $723 |
| Humulin R U-500 Kwikpen | 28 | $38,091 | $1,360 |
| Humalog Kwikpen U-200 | 22 | $34,000 | $1,545 |
| Humalog | 27 | $25,384 | $940 |
| Nano 2nd Gen Pen Needle | 222 | $20,701 | $93 |
| Prolia | 11 | $18,593 | $1,690 |
| Lantus | 24 | $14,729 | $614 |
| Basaglar Kwikpen U-100 | 23 | $13,797 | $600 |
| Repatha Sureclick | 19 | $13,536 | $712 |
| Toujeo Max Solostar | 12 | $11,103 | $925 |
| Insulin Lispro Kwikpen U-100 | 50 | $10,030 | $201 |
| Repaglinide | 114 | $8,248 | $72 |
| Cinacalcet | 12 | $6,580 | $548 |
| Testosterone | 14 | $4,891 | $349 |
| Levothyroxine | 291 | $4,561 | $16 |
| Synthroid | 40 | $3,411 | $85 |
| Fenofibrate | 13 | $2,603 | $200 |
| Ultra-Fine Nano Pen Needle | 16 | $2,287 | $143 |
| Metformin | 146 | $2,051 | $14 |
| Ultra-Fine Mini Pen Needle | 21 | $1,864 | $89 |
| Ultra-Fine Short Pen Needle | 19 | $1,824 | $96 |
| Metformin Hcl Er | 117 | $1,700 | $15 |
| Insulin | 32 | $1,492 | $47 |
| Atorvastatin | 95 | $1,447 | $15 |
| Glimepiride | 29 | $1,302 | $45 |
| Testosterone Cypionate | 24 | $1,220 | $51 |
| Calcitriol | 27 | $1,216 | $45 |
| Losartan | 65 | $840 | $13 |
| Gabapentin | 45 | $679 | $15 |
| Alendronate | 47 | $676 | $14 |
| Amlodipine Besylate | 66 | $660 | $10 |
| Rosuvastatin | 43 | $556 | $13 |
| Lisinopril | 41 | $409 | $10 |
| Metoprolol | 13 | $388 | $30 |
| Hydrocortisone | 19 | $373 | $20 |
| Simvastatin | 30 | $314 | $10 |
| Glipizide | 25 | $228 | $9 |
| Methimazole | 18 | $179 | $10 |
| Hydrochlorothiazide | 22 | $87 | $4 |
| Losartan-Hydrochlorothiazide | 14 | $62 | $4 |
2022: 47 drugs
| Trulicity | 224 | $329,411 | $1,471 |
| Ozempic | 167 | $276,424 | $1,655 |
| Jardiance | 326 | $268,521 | $824 |
| Lantus Solostar | 214 | $132,964 | $621 |
| Humalog Kwikpen U-100 | 109 | $74,460 | $683 |
| Tresiba Flextouch U-200 | 51 | $62,534 | $1,226 |
| Humalog Kwikpen U-200 | 21 | $38,330 | $1,825 |
| Novolog Flexpen | 47 | $37,422 | $796 |
| Humalog | 23 | $27,395 | $1,191 |
| Farxiga | 43 | $27,042 | $629 |
| Tresiba Flextouch U-100 | 43 | $26,837 | $624 |
| Humulin R U-500 Kwikpen | 17 | $26,769 | $1,575 |
| Nano 2nd Gen Pen Needle | 186 | $17,454 | $94 |
| Insulin Lispro Kwikpen U-100 | 78 | $15,447 | $198 |
| Lantus | 25 | $13,489 | $540 |
| Repatha Sureclick | 16 | $11,813 | $738 |
| Testosterone | 18 | $11,755 | $653 |
| Fiasp Flextouch | 15 | $9,448 | $630 |
| Praluent | 12 | $6,059 | $505 |
| Repaglinide | 76 | $5,198 | $68 |
| Levothyroxine | 205 | $3,767 | $18 |
| Synthroid | 74 | $3,509 | $47 |
| Insulin Lispro | 11 | $2,284 | $208 |
| Ultra-Fine Mini Pen Needle | 24 | $2,136 | $89 |
| Metformin Hcl Er | 86 | $1,965 | $23 |
| Ultra-Fine Short Pen Needle | 15 | $1,619 | $108 |
| Insulin | 27 | $1,573 | $58 |
| Metformin | 114 | $1,486 | $13 |
| Atorvastatin | 80 | $1,421 | $18 |
| Ultra-Fine Nano Pen Needle | 17 | $1,408 | $83 |
| Glimepiride | 54 | $1,300 | $24 |
| Testosterone Cypionate | 14 | $1,071 | $76 |
| Calcitriol | 17 | $879 | $52 |
| Rosuvastatin | 29 | $721 | $25 |
| Gabapentin | 49 | $571 | $12 |
| Pregabalin | 13 | $565 | $43 |
| Metoprolol | 29 | $466 | $16 |
| Losartan | 41 | $449 | $11 |
| Nifedipine Er | 21 | $392 | $19 |
| Lisinopril | 61 | $378 | $6 |
| Alendronate | 37 | $349 | $9 |
| Simvastatin | 27 | $339 | $13 |
| Amlodipine Besylate | 37 | $196 | $5 |
| Euthyrox | 12 | $113 | $9 |
| Glipizide | 19 | $75 | $4 |
| Methimazole | 11 | $69 | $6 |
| Hydrochlorothiazide | 18 | $44 | $2 |
2021: 44 drugs
| Trulicity | 202 | $250,870 | $1,242 |
| Ozempic | 155 | $227,812 | $1,470 |
| Jardiance | 215 | $160,203 | $745 |
| Lantus Solostar | 223 | $112,767 | $506 |
| Humalog Kwikpen U-100 | 123 | $73,662 | $599 |
| Tresiba Flextouch U-200 | 42 | $56,975 | $1,357 |
| Tresiba Flextouch U-100 | 58 | $33,941 | $585 |
| Humalog Kwikpen U-200 | 19 | $28,480 | $1,499 |
| Novolog Flexpen | 44 | $28,400 | $645 |
| Humulin R U-500 Kwikpen | 18 | $25,713 | $1,428 |
| Insulin Lispro Kwikpen U-100 | 84 | $24,977 | $297 |
| Rybelsus | 22 | $20,468 | $930 |
| Humalog | 15 | $15,079 | $1,005 |
| Lantus | 27 | $14,868 | $551 |
| Nano 2nd Gen Pen Needle | 166 | $14,644 | $88 |
| Testosterone | 26 | $13,186 | $507 |
| Fiasp Flextouch | 17 | $9,983 | $587 |
| Repaglinide | 80 | $5,204 | $65 |
| Vascepa | 12 | $4,367 | $364 |
| Levothyroxine | 194 | $3,912 | $20 |
| Ultra-Fine Nano Pen Needle | 28 | $2,349 | $84 |
| Synthroid | 45 | $2,218 | $49 |
| Ultra-Fine Mini Pen Needle | 23 | $1,896 | $82 |
| Metformin | 131 | $1,270 | $10 |
| Atorvastatin | 67 | $1,024 | $15 |
| Metformin Hcl Er | 65 | $972 | $15 |
| Gabapentin | 56 | $921 | $16 |
| Rosuvastatin | 17 | $883 | $52 |
| Insulin | 15 | $781 | $52 |
| Glimepiride | 35 | $733 | $21 |
| Cabergoline | 12 | $680 | $57 |
| Testosterone Cypionate | 12 | $617 | $51 |
| Metoprolol | 33 | $590 | $18 |
| Losartan | 40 | $573 | $14 |
| Progesterone | 14 | $317 | $23 |
| Lisinopril | 56 | $259 | $5 |
| Methimazole | 25 | $232 | $9 |
| Hydrocortisone | 14 | $210 | $15 |
| Simvastatin | 28 | $199 | $7 |
| Alendronate | 22 | $191 | $9 |
| Amlodipine Besylate | 34 | $164 | $5 |
| Glipizide | 15 | $158 | $11 |
| Euthyrox | 19 | $88 | $5 |
| Hydrochlorothiazide | 11 | $28 | $3 |
2020: 37 drugs
| Trulicity | 130 | $157,771 | $1,214 |
| Ozempic | 99 | $116,876 | $1,181 |
| Lantus Solostar | 153 | $77,443 | $506 |
| Humalog Kwikpen U-100 | 93 | $53,692 | $577 |
| Jardiance | 69 | $49,355 | $715 |
| Tresiba Flextouch U-200 | 32 | $48,334 | $1,510 |
| Novolog Flexpen | 62 | $47,807 | $771 |
| Humulin R U-500 Kwikpen | 38 | $38,943 | $1,025 |
| Tresiba Flextouch U-100 | 70 | $32,951 | $471 |
| Testosterone | 21 | $14,821 | $706 |
| Humalog Kwikpen U-200 | 11 | $12,999 | $1,182 |
| Insulin Lispro Kwikpen U-100 | 46 | $11,527 | $251 |
| Ultra-Fine Nano Pen Needle | 126 | $10,289 | $82 |
| Lantus | 20 | $10,060 | $503 |
| Fiasp Flextouch | 16 | $9,534 | $596 |
| Toujeo Solostar | 11 | $7,849 | $714 |
| Janumet Xr | 12 | $5,867 | $489 |
| Basaglar Kwikpen U-100 | 19 | $5,700 | $300 |
| Nano 2nd Gen Pen Needle | 50 | $4,123 | $82 |
| Repaglinide | 45 | $3,024 | $67 |
| Levothyroxine | 121 | $2,451 | $20 |
| Ultra-Fine Mini Pen Needle | 24 | $2,040 | $85 |
| Synthroid | 24 | $1,610 | $67 |
| Gabapentin | 60 | $1,362 | $23 |
| Metformin | 149 | $1,326 | $9 |
| Novofine 32 | 13 | $975 | $75 |
| Pen Needles | 14 | $835 | $60 |
| Ultra-Fine Short Pen Needle | 14 | $819 | $58 |
| Atorvastatin | 46 | $751 | $16 |
| Metformin Hcl Er | 43 | $703 | $16 |
| Glimepiride | 40 | $540 | $13 |
| Losartan | 32 | $337 | $11 |
| Amlodipine Besylate | 40 | $298 | $7 |
| Alendronate | 28 | $285 | $10 |
| Lisinopril | 43 | $249 | $6 |
| Methimazole | 14 | $206 | $15 |
| Simvastatin | 18 | $108 | $6 |
2019: 43 drugs
| Trulicity | 331 | $324,245 | $980 |
| Novolog Flexpen | 181 | $128,521 | $710 |
| Tresiba Flextouch U-200 | 111 | $112,605 | $1,014 |
| Humulin R U-500 Kwikpen | 102 | $102,796 | $1,008 |
| Humalog Kwikpen U-100 | 124 | $80,566 | $650 |
| Lantus Solostar | 132 | $74,965 | $568 |
| Ozempic | 62 | $60,001 | $968 |
| Tresiba Flextouch U-100 | 127 | $58,844 | $463 |
| Toujeo Solostar | 69 | $50,867 | $737 |
| Victoza 3-Pak | 20 | $44,872 | $2,244 |
| Jardiance | 61 | $36,220 | $594 |
| Humulin R U-500 | 15 | $28,292 | $1,886 |
| Fiasp Flextouch | 30 | $18,182 | $606 |
| Prolia | 14 | $17,778 | $1,270 |
| Ultra-Fine Nano Pen Needle | 188 | $17,465 | $93 |
| Humalog | 15 | $16,898 | $1,127 |
| Basaglar Kwikpen U-100 | 55 | $16,852 | $306 |
| Humalog Kwikpen U-200 | 11 | $11,508 | $1,046 |
| Farxiga | 13 | $6,495 | $500 |
| Repaglinide | 73 | $4,324 | $59 |
| Easy Comfort Pen Needles | 18 | $3,762 | $209 |
| Levothyroxine | 172 | $3,210 | $19 |
| Ultra-Fine Mini Pen Needle | 39 | $3,107 | $80 |
| Metformin | 248 | $2,272 | $9 |
| Ultra-Fine Short Pen Needle | 19 | $1,700 | $89 |
| Atorvastatin | 91 | $1,215 | $13 |
| Pen Needles | 13 | $1,138 | $88 |
| Calcitriol | 13 | $791 | $61 |
| Gabapentin | 55 | $776 | $14 |
| Duloxetine | 17 | $722 | $42 |
| Glimepiride | 35 | $613 | $18 |
| Easy Touch Pen Needle | 21 | $591 | $28 |
| Losartan | 48 | $434 | $9 |
| Simvastatin | 53 | $387 | $7 |
| Amlodipine Besylate | 71 | $363 | $5 |
| Lisinopril | 46 | $354 | $8 |
| Hydrocortisone | 13 | $266 | $20 |
| Alendronate | 35 | $212 | $6 |
| Metformin Hcl Er | 14 | $148 | $11 |
| Methimazole | 11 | $137 | $12 |
| Atenolol | 25 | $117 | $5 |
| Hydrochlorothiazide | 19 | $88 | $5 |
| Omeprazole | 14 | $49 | $4 |
2018: 42 drugs
| Trulicity | 315 | $314,689 | $999 |
| Novolog Flexpen | 250 | $158,471 | $634 |
| Tresiba Flextouch U-200 | 168 | $154,574 | $920 |
| Humulin R U-500 Kwikpen | 96 | $107,105 | $1,116 |
| Humalog Kwikpen U-100 | 121 | $91,635 | $757 |
| Victoza 3-Pak | 69 | $86,766 | $1,257 |
| Lantus Solostar | 145 | $76,069 | $525 |
| Toujeo Solostar | 110 | $64,531 | $587 |
| Tresiba Flextouch U-100 | 119 | $50,873 | $428 |
| Humulin R U-500 | 11 | $48,903 | $4,446 |
| Jardiance | 31 | $21,215 | $684 |
| Humalog | 24 | $20,451 | $852 |
| Invokana | 39 | $19,568 | $502 |
| Basaglar Kwikpen U-100 | 62 | $18,901 | $305 |
| Ultra-Fine Nano Pen Needle | 212 | $18,159 | $86 |
| Bydureon | 19 | $16,079 | $846 |
| Farxiga | 15 | $6,925 | $462 |
| Ultra-Fine Mini Pen Needle | 65 | $5,495 | $85 |
| Xigduo Xr | 13 | $5,222 | $402 |
| Levothyroxine | 262 | $4,627 | $18 |
| Novolog | 12 | $3,989 | $332 |
| Repaglinide | 43 | $2,890 | $67 |
| Metformin | 312 | $2,571 | $8 |
| Ultra-Fine Short Pen Needle | 25 | $1,788 | $72 |
| Gabapentin | 71 | $1,276 | $18 |
| Glimepiride | 66 | $1,232 | $19 |
| Atorvastatin | 94 | $1,166 | $12 |
| Ulticare Pen Needle | 16 | $1,105 | $69 |
| Duloxetine | 27 | $1,042 | $39 |
| Testosterone Cypionate | 12 | $625 | $52 |
| Losartan | 58 | $424 | $7 |
| Amlodipine Besylate | 65 | $352 | $5 |
| Simvastatin | 53 | $308 | $6 |
| Lisinopril | 28 | $255 | $9 |
| Cartia Xt | 15 | $234 | $16 |
| Easy Touch Pen Needle | 13 | $229 | $18 |
| Hydrochlorothiazide | 38 | $229 | $6 |
| Alendronate | 22 | $100 | $5 |
| Methimazole | 15 | $92 | $6 |
| Clonidine | 17 | $85 | $5 |
| Furosemide | 17 | $66 | $4 |
| Atenolol | 14 | $55 | $4 |
2017: 48 drugs
| Trulicity | 182 | $155,931 | $857 |
| Tresiba Flextouch U-200 | 176 | $146,694 | $833 |
| Novolog Flexpen | 185 | $125,265 | $677 |
| Humulin R U-500 Kwikpen | 112 | $93,974 | $839 |
| Victoza 3-Pak | 71 | $86,692 | $1,221 |
| Humalog Kwikpen U-100 | 110 | $77,628 | $706 |
| Lantus Solostar | 148 | $68,496 | $463 |
| Toujeo Solostar | 142 | $60,116 | $423 |
| Humulin R U-500 | 19 | $49,756 | $2,619 |
| Forteo | 13 | $38,914 | $2,993 |
| Invokana | 65 | $38,753 | $596 |
| Tresiba Flextouch U-100 | 65 | $29,088 | $448 |
| Jardiance | 37 | $20,132 | $544 |
| Bydureon | 28 | $19,978 | $714 |
| Androgel | 14 | $18,493 | $1,321 |
| Humalog | 37 | $18,063 | $488 |
| Novolog | 24 | $16,785 | $699 |
| Ultra-Fine Nano Pen Needle | 188 | $15,844 | $84 |
| Lantus | 20 | $7,534 | $377 |
| Farxiga | 12 | $5,214 | $434 |
| Levothyroxine | 247 | $4,520 | $18 |
| Ultra-Fine Mini Pen Needle | 57 | $4,295 | $75 |
| Xigduo Xr | 11 | $3,302 | $300 |
| Metformin | 302 | $2,258 | $7 |
| Repaglinide | 33 | $2,117 | $64 |
| Ultra-Fine Short Pen Needle | 32 | $1,935 | $60 |
| Bd Ultra-Fine Pen Needle | 16 | $1,827 | $114 |
| Gabapentin | 110 | $1,374 | $12 |
| Atorvastatin | 87 | $1,100 | $13 |
| Duloxetine | 22 | $940 | $43 |
| Glimepiride | 51 | $793 | $16 |
| Losartan | 80 | $594 | $7 |
| Pen Needles | 11 | $591 | $54 |
| Unifine Pentips | 20 | $536 | $27 |
| Insulin | 11 | $535 | $49 |
| Insulin | 12 | $504 | $42 |
| Novofine Plus | 13 | $406 | $31 |
| Simvastatin | 45 | $335 | $7 |
| Amlodipine Besylate | 68 | $326 | $5 |
| Hydrochlorothiazide | 39 | $304 | $8 |
| Lisinopril | 42 | $257 | $6 |
| Propranolol | 13 | $239 | $18 |
| Clonidine | 20 | $111 | $6 |
| Alendronate | 12 | $89 | $7 |
| Losartan-Hydrochlorothiazide | 12 | $89 | $7 |
| Methimazole | 18 | $89 | $5 |
| Omeprazole | 12 | $87 | $7 |
| Furosemide | 17 | $78 | $5 |
2016: 44 drugs
| Toujeo Solostar | 238 | $113,021 | $475 |
| Novolog Flexpen | 175 | $102,813 | $588 |
| Lantus Solostar | 185 | $98,192 | $531 |
| Trulicity | 105 | $80,823 | $770 |
| Humalog Kwikpen U-100 | 117 | $69,265 | $592 |
| Victoza 3-Pak | 74 | $65,179 | $881 |
| Humulin R U-500 | 29 | $54,239 | $1,870 |
| Lantus | 73 | $32,867 | $450 |
| Invokana | 47 | $32,161 | $684 |
| Humalog | 63 | $24,379 | $387 |
| Bydureon | 34 | $21,508 | $633 |
| Novolog | 31 | $20,065 | $647 |
| Androgel | 19 | $18,877 | $994 |
| Bd Ultra-Fine Pen Needle | 211 | $18,062 | $86 |
| Tresiba Flextouch U-200 | 24 | $17,592 | $733 |
| Humulin R U-500 Kwikpen | 24 | $16,383 | $683 |
| Jardiance | 33 | $15,528 | $471 |
| Levemir Flextouch | 19 | $8,501 | $447 |
| Tresiba Flextouch U-100 | 12 | $5,390 | $449 |
| Xigduo Xr | 11 | $4,316 | $392 |
| Levothyroxine | 190 | $4,041 | $21 |
| Metformin | 239 | $2,039 | $9 |
| Repaglinide | 29 | $1,883 | $65 |
| Gabapentin | 83 | $1,234 | $15 |
| Insulin | 32 | $1,128 | $35 |
| Pen Needles | 11 | $939 | $85 |
| Glimepiride | 66 | $878 | $13 |
| Atorvastatin | 38 | $842 | $22 |
| Unifine Pentips | 30 | $798 | $27 |
| Insulin | 27 | $685 | $25 |
| Duloxetine | 12 | $514 | $43 |
| Amlodipine Besylate | 64 | $481 | $8 |
| Lisinopril | 47 | $436 | $9 |
| Sure Comfort | 11 | $307 | $28 |
| Simvastatin | 46 | $257 | $6 |
| Losartan | 32 | $207 | $6 |
| Hydrochlorothiazide | 16 | $178 | $11 |
| Propranolol | 18 | $174 | $10 |
| Clonidine | 23 | $131 | $6 |
| Glipizide | 13 | $99 | $8 |
| Clopidogrel | 11 | $93 | $8 |
| Atenolol | 14 | $86 | $6 |
| Omeprazole | 13 | $72 | $6 |
| Furosemide | 25 | $58 | $2 |
2015: 41 drugs
| Lantus Solostar | 228 | $121,265 | $532 |
| Novolog Flexpen | 143 | $79,010 | $553 |
| Victoza 3-Pak | 83 | $64,628 | $779 |
| Humulin R U-500 | 28 | $52,679 | $1,881 |
| Lantus | 102 | $44,096 | $432 |
| Bydureon | 55 | $31,590 | $574 |
| Invokana | 51 | $27,850 | $546 |
| Toujeo Solostar | 64 | $26,339 | $412 |
| Trulicity | 36 | $23,216 | $645 |
| Humalog Kwikpen U-100 | 45 | $22,286 | $495 |
| Novolog | 50 | $21,972 | $439 |
| Levemir Flextouch | 39 | $20,029 | $514 |
| Androgel | 24 | $16,454 | $686 |
| Humalog | 45 | $12,656 | $281 |
| Jardiance | 20 | $11,754 | $588 |
| Bd Ultra-Fine Pen Needle | 141 | $9,353 | $66 |
| Repaglinide | 22 | $6,370 | $290 |
| Onglyza | 13 | $4,792 | $369 |
| Levemir | 14 | $4,118 | $294 |
| Cabergoline | 17 | $3,916 | $230 |
| Levothyroxine | 161 | $3,713 | $23 |
| Metformin | 225 | $1,830 | $8 |
| Insulin | 35 | $1,441 | $41 |
| Glimepiride | 106 | $1,137 | $11 |
| Insulin | 23 | $1,012 | $44 |
| Fenofibrate | 12 | $967 | $81 |
| Insulin | 32 | $758 | $24 |
| Gabapentin | 41 | $758 | $18 |
| Atorvastatin | 25 | $695 | $28 |
| Unifine Pentips | 17 | $547 | $32 |
| Simvastatin | 54 | $422 | $8 |
| Sure Comfort | 12 | $384 | $32 |
| Enalapril Maleate | 11 | $346 | $31 |
| Lisinopril | 49 | $281 | $6 |
| Hydrocortisone | 13 | $276 | $21 |
| Amlodipine Besylate | 41 | $273 | $7 |
| Losartan | 23 | $271 | $12 |
| Methimazole | 13 | $227 | $17 |
| Clonidine | 27 | $196 | $7 |
| Cartia Xt | 11 | $190 | $17 |
| Furosemide | 15 | $24 | $2 |
2014: 30 drugs
| Lantus Solostar | 211 | $99,283 | $471 |
| Novolog Flexpen | 156 | $72,491 | $465 |
| Victoza 3-Pak | 94 | $71,932 | $765 |
| Humulin R | 16 | $30,028 | $1,877 |
| Humalog | 56 | $20,558 | $367 |
| Repaglinide | 37 | $19,247 | $520 |
| Lantus | 41 | $17,471 | $426 |
| Novolog | 47 | $14,783 | $315 |
| Levemir Flexpen | 29 | $11,565 | $399 |
| Bd Ultra-Fine Pen Needle | 146 | $9,851 | $67 |
| Tradjenta | 15 | $8,057 | $537 |
| Onglyza | 17 | $7,179 | $422 |
| Levemir Flextouch | 18 | $6,605 | $367 |
| Byetta | 11 | $6,413 | $583 |
| Diovan | 19 | $3,821 | $201 |
| Levothyroxine | 136 | $2,312 | $17 |
| Metformin | 206 | $2,152 | $10 |
| Duloxetine | 11 | $1,861 | $169 |
| Insulin | 18 | $907 | $50 |
| Glimepiride | 59 | $792 | $13 |
| Atorvastatin | 21 | $350 | $17 |
| Gabapentin | 17 | $335 | $20 |
| Simvastatin | 39 | $331 | $8 |
| Losartan | 28 | $297 | $11 |
| Amlodipine Besylate | 50 | $290 | $6 |
| Lisinopril | 43 | $225 | $5 |
| Enalapril Maleate | 13 | $216 | $17 |
| Metoprolol | 18 | $153 | $9 |
| Glipizide | 11 | $102 | $9 |
| Synthroid | 12 | $29 | $2 |
2013: 26 drugs
| Lantus Solostar | 216 | $69,231 | $321 |
| Novolog Flexpen | 121 | $38,157 | $315 |
| Humalog | 48 | $18,845 | $393 |
| Victoza 3-Pak | 19 | $9,650 | $508 |
| Prandin | 21 | $9,408 | $448 |
| Repaglinide | 13 | $7,984 | $614 |
| Bd Ultra-Fine Pen Needle | 130 | $7,971 | $61 |
| Levemir Flexpen | 26 | $6,797 | $261 |
| Lantus | 11 | $4,976 | $452 |
| Diovan | 26 | $4,548 | $175 |
| Victoza 2-Pak | 11 | $3,734 | $339 |
| Novolog | 15 | $3,717 | $248 |
| Cymbalta | 11 | $2,839 | $258 |
| Metformin | 194 | $1,877 | $10 |
| Levothyroxine | 115 | $1,201 | $10 |
| Metformin Hcl Er | 12 | $605 | $50 |
| Lisinopril | 82 | $501 | $6 |
| Atorvastatin | 22 | $463 | $21 |
| Simvastatin | 40 | $356 | $9 |
| Amlodipine Besylate | 45 | $318 | $7 |
| Methimazole | 13 | $292 | $22 |
| Labetalol | 11 | $228 | $21 |
| Glimepiride | 32 | $217 | $7 |
| Losartan | 17 | $192 | $11 |
| Benazepril | 17 | $157 | $9 |
| Hydrochlorothiazide | 15 | $75 | $5 |
Money from drug and device companies
$28,819 in 2025
| 2025 | 5 | 67 | $24,075 | $28,819 |
| 2024 | 2 | 18 | $5,213 | $6,720 |
| 2023 | 2 | 65 | $23,050 | $32,496 |
| 2022 | 3 | 4 | None | $112 |
| 2021 | 2 | 5 | None | $102 |
| 2020 | 3 | 6 | None | $95 |
| 2019 | 18 | 112 | None | $1,435 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Freestyle Libre 3 | $28,581 | 62 payments
|
| Sanofi-Aventis U.S. | Tzield | $150 | 1 payment
|
| Novo Nordisk | Rybelsus | $32 | 2 payments
|
| Medtronic | Minimed 780g | $31 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $25 | 1 payment
|
See all 67 published payments
| Abbott Laboratories | Paid to speak or teach · 2025-12-19 | Freestyle Libre 3 | $900 |
| Abbott Laboratories | Paid to speak or teach · 2025-12-19 | Freestyle Libre 3 | $1,200 |
| Abbott Laboratories | Paid to speak or teach · 2025-12-19 | Freestyle Libre 3 | $1,125 |
| Dexcom | Meals · 2025-12-10 | Dexcom G6 Transmitter | $25 |
| Abbott Laboratories | Meals · 2025-11-27 | Freestyle Libre 3 | $150 |
| Abbott Laboratories | Meals · 2025-10-30 | Freestyle Libre 3 | $56 |
| Abbott Laboratories | Travel · 2025-10-29 | Freestyle Libre 3 | $45 |
| Abbott Laboratories | Travel · 2025-10-29 | Freestyle Libre 3 | $194 |
| Novo Nordisk | Meals · 2025-10-22 | Rybelsus | $17 |
| Abbott Laboratories | Paid to speak or teach · 2025-10-17 | Freestyle Libre 3 | $900 |
| Abbott Laboratories | Paid to speak or teach · 2025-10-17 | Freestyle Libre 3 | $900 |
| Abbott Laboratories | Travel · 2025-10-17 | Freestyle Libre 3 | $30 |
| Medtronic | Meals · 2025-10-06 | Minimed 780g | $31 |
| Abbott Laboratories | Meals · 2025-10-02 | Freestyle Libre 3 | $85 |
| Novo Nordisk | Meals · 2025-09-16 | Rybelsus | $15 |
| Abbott Laboratories | Paid to speak or teach · 2025-09-12 | Freestyle Libre 3 | $600 |
| Abbott Laboratories | Paid to speak or teach · 2025-09-12 | Freestyle Libre 3 | $900 |
| Abbott Laboratories | Paid to speak or teach · 2025-09-12 | Freestyle Libre 3 | $300 |
| Abbott Laboratories | Paid to speak or teach · 2025-09-12 | Freestyle Libre 3 | $300 |
| Abbott Laboratories | Meals · 2025-07-24 | Freestyle Libre 3 | $147 |
| Abbott Laboratories | Meals · 2025-07-10 | Freestyle Libre 3 | $11 |
| Abbott Laboratories | Meals · 2025-07-08 | Freestyle Libre 3 | $16 |
| Abbott Laboratories | Meals · 2025-07-08 | Freestyle Libre 3 | $16 |
| Abbott Laboratories | Meals · 2025-07-07 | Freestyle Libre 3 | $17 |
| Abbott Laboratories | Paid to speak or teach · 2025-06-27 | Freestyle Libre 3 | $375 |
| Abbott Laboratories | Paid to speak or teach · 2025-06-27 | Freestyle Libre 3 | $1,800 |
| Abbott Laboratories | Paid to speak or teach · 2025-06-27 | Freestyle Libre 3 | $900 |
| Abbott Laboratories | Paid to speak or teach · 2025-06-27 | Freestyle Libre 3 | $900 |
| Abbott Laboratories | Paid to speak or teach · 2025-06-27 | Freestyle Libre 3 | $375 |
| Abbott Laboratories | Paid to speak or teach · 2025-05-27 | Freestyle Libre 3 | $900 |
| Abbott Laboratories | Meals · 2025-05-08 | Freestyle Libre 3 | $38 |
| Abbott Laboratories | Consulting · 2025-04-30 | Freestyle Libre 3 | $4,500 |
| Abbott Laboratories | Meals · 2025-04-23 | Freestyle Libre 3 | $151 |
| Abbott Laboratories | Travel · 2025-04-23 | Freestyle Libre 3 | $177 |
| Abbott Laboratories | Travel · 2025-04-22 | Freestyle Libre 3 | $177 |
| Abbott Laboratories | Travel · 2025-04-22 | Freestyle Libre 3 | $9 |
| Abbott Laboratories | Meals · 2025-04-09 | Freestyle Libre 3 | $9 |
| Abbott Laboratories | Meals · 2025-04-09 | Freestyle Libre 3 | $97 |
| Abbott Laboratories | Meals · 2025-03-29 | Freestyle Libre 3 | $140 |
| Abbott Laboratories | Meals · 2025-03-29 | Freestyle Libre 3 | $49 |
| Abbott Laboratories | Meals · 2025-03-29 | Freestyle Libre 3 | $71 |
| Abbott Laboratories | Meals · 2025-03-29 | Freestyle Libre 3 | $52 |
| Abbott Laboratories | Meals · 2025-03-28 | Freestyle Libre 3 | $79 |
| Abbott Laboratories | Meals · 2025-03-28 | Freestyle Libre 3 | $53 |
| Abbott Laboratories | Meals · 2025-03-28 | Freestyle Libre 3 | $140 |
| Abbott Laboratories | Travel · 2025-03-28 | Freestyle Libre 3 | $754 |
| Abbott Laboratories | Travel · 2025-03-28 | Freestyle Libre 3 | $200 |
| Abbott Laboratories | Meals · 2025-03-26 | Freestyle Libre 3 | $83 |
| Sanofi-Aventis U.S. | Meals · 2025-03-19 | Tzield | $150 |
| Abbott Laboratories | Meals · 2025-03-11 | Freestyle Libre 3 | $26 |
| Abbott Laboratories | Paid to speak or teach · 2025-03-07 | Freestyle Libre 3 | $1,950 |
| Abbott Laboratories | Paid to speak or teach · 2025-03-07 | Freestyle Libre 3 | $1,425 |
| Abbott Laboratories | Paid to speak or teach · 2025-03-07 | Freestyle Libre 3 | $1,050 |
| Abbott Laboratories | Paid to speak or teach · 2025-03-07 | Freestyle Libre 3 | $900 |
| Abbott Laboratories | Paid to speak or teach · 2025-03-07 | Freestyle Libre 3 | $450 |
| Abbott Laboratories | Paid to speak or teach · 2025-03-07 | Freestyle Libre 3 | $675 |
| Abbott Laboratories | Paid to speak or teach · 2025-03-07 | Freestyle Libre 3 | $750 |
| Abbott Laboratories | Travel · 2025-03-07 | Freestyle Libre 3 | $450 |
| Abbott Laboratories | Meals · 2025-02-07 | Freestyle Libre 3 | $131 |
| Abbott Laboratories | Meals · 2025-02-07 | Freestyle Libre 3 | $19 |
| Abbott Laboratories | Travel · 2025-02-05 | Freestyle Libre 3 | $149 |
| Abbott Laboratories | Travel · 2025-02-05 | Freestyle Libre 3 | $45 |
| Abbott Laboratories | Travel · 2025-02-05 | Freestyle Libre 3 | $149 |
| Abbott Laboratories | Meals · 2025-01-30 | Freestyle Libre 3 | $84 |
| Abbott Laboratories | Travel · 2025-01-30 | Freestyle Libre 3 | $183 |
| Abbott Laboratories | Travel · 2025-01-30 | Freestyle Libre 3 | $45 |
| Abbott Laboratories | Travel · 2025-01-30 | Freestyle Libre 3 | $183 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $6,720
| Abbott Laboratories | Freestyle Libre 3 | $6,592 | 12 payments
|
| Lilly USA | Mounjaro | $128 | 6 payments
|
2023: $32,496
| Lilly USA | Mounjaro | $20,402 | 43 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $12,095 | 22 payments
|
2022: $112
| Merck Sharp & Dohme | Verquvo | $73 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $27 | 2 payments
|
| Lilly USA | None | $12 | 1 payment
|
2021: $102
| Abbott Laboratories | Freestyle Libre 2 | $72 | 3 payments
|
| Novo Nordisk | Ozempic | $30 | 2 payments
|
2020: $95
| Novo Nordisk | Ozempic | $63 | 4 payments
|
| Lilly USA | Baqsimi | $16 | 1 payment
|
| Abbott Laboratories | Freestyle Libre Pro | $15 | 1 payment
|
2019: $1,435
| Novo Nordisk | Ozempic | $448 | 50 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $174 | 9 payments
|
| Boehringer Ingelheim Pharmaceuticals | Tradjenta | $132 | 10 payments
|
| Janssen Pharmaceuticals | Xarelto | $110 | 8 payments
|
| Sanofi-Aventis U.S. | Toujeo | $107 | 1 payment
|
| LivaNova USA | Vns Therapy | $84 | 1 payment
|
| Amgen | Repatha | $79 | 3 payments
|
| Akcea Therapeutics | Tegsedi | $55 | 1 payment
|
| Amarin Pharma | Vascepa | $52 | 3 payments
|
| Merck Sharp & Dohme | Januvia | $49 | 4 payments
|
| Genentech USA | Xofluza | $36 | 2 payments
|
| Ferring Pharmaceuticals | Zomacton | $28 | 1 payment
|
| Companion Medical | Inpen | $16 | 2 payments
|
| Corcept Therapeutics | Korlym | $14 | 1 payment
|
| Mannkind | Afrezza | $14 | 1 payment
|
| Insulet | Omnipod | $13 | 1 payment
|
| Lilly USA | Trulicity | $12 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1225066947
- Licence
- CA A75781California A75781: Current · expires 2027-06-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A757810
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 2585 Samaritan Dr, San Jose, CA, 95124
- NPI first listed
- 2006-06-29
- NPI last updated
- 2020-11-11
- NPI record certified
- 2020-11-11
This is when the NPI record was last certified, not a medical board exam.